Celldex Therapeutics, Inc. (CLDX) revenue

Revenue · fiscal 2025
$1.55M

Celldex Therapeutics, Inc. (CLDX) reported revenue of $1.55M in fiscal 2025 (the year ended December 31, 2025). That is 78.0% lower than the $7.02M of fiscal 2024. Figures as of 18 Nov 2026, 06:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$1.55M
Change on fiscal 2024
−78.0%
Growth, 5 years
−26.9% a year
Growth, 10 years
−11.9% a year
Highest on record
$46.79Mfiscal 2010
Lowest on record
$1.55Mfiscal 2025
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Celldex Therapeutics, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 26.9% a year; over ten years the rate was −11.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $46.79M in fiscal 2010 and the lowest $1.55M in fiscal 2025.

History · 17 fiscal years

Revenue by fiscal year

Celldex Therapeutics, Inc. revenue, year by year

Celldex Therapeutics, Inc. (CLDX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$1.55M 78.0% down
2024$7.02M 2.0% up
2023$6.88M 192.0% up
2022$2.36M 49.3% down
2021$4.65M 37.3% down
2020$7.42M 107.6% up
2019$3.57M 62.5% down
2018$9.54M 25.2% down
2017$12.74M 87.8% up
2016$6.79M 23.8% up
2015$5.48M 52.8% up
2014$3.59M 12.8% down
2013$4.11M 63.3% down
2012$11.20M 20.9% up
2011$9.27M 80.2% down
2010$46.79M 208.3% up
2009$15.18M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on CLDX

Celldex Therapeutics, Inc., figure by figure

Celldex Therapeutics, Inc. (CLDX) overview: price, valuation and scorecard

Celldex Therapeutics, Inc. revenue: questions and answers

What is Celldex Therapeutics, Inc.'s revenue?

Celldex Therapeutics, Inc. (CLDX) reported revenue of $1.55M in fiscal 2025 (the year ended December 31, 2025). That is 78.0% lower than the $7.02M of fiscal 2024.

What is the growth rate of Celldex Therapeutics, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 26.9% a year; over ten years the rate was −11.9% a year.

What are the highest and lowest revenue figures on record for Celldex Therapeutics, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $46.79M in fiscal 2010 and the lowest $1.55M in fiscal 2025.

How is Celldex Therapeutics, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Celldex Therapeutics, Inc. (CLDX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/CLDX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.